Department of Structural Biology and Biomolecular Engineering, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan.
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4034-9. doi: 10.1073/pnas.0908526107. Epub 2010 Feb 8.
Combined deficiency of coagulation factors V and VIII (F5F8D), an autosomal recessive disorder characterized by coordinate reduction in the plasma levels of factor V (FV) and factor VIII (FVIII), is genetically linked to mutations in the transmembrane lectin ERGIC-53 and the soluble calcium-binding protein MCFD2. Growing evidence indicates that these two proteins form a complex recycling between the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment and thereby function as a cargo receptor in the early secretory pathway of FV and FVIII. For better understanding of the mechanisms underlying the functional coordination of ERGIC-53 and MCFD2, we herein characterize their interaction by x-ray crystallographic analysis in conjunction with NMR and ultracentrifugation analyses. Inspection of the combined data reveals that ERGIC-53-CRD binds MCFD2 through its molecular surface remote from the sugar-binding site, giving rise to a 11 complex in solution. The interaction is independent of sugar-binding of ERGIC-53 and involves most of the missense mutation sites of MCFD2 so far reported in F5F8D. Comparison with the previously reported uncomplexed structure of each protein indicates that MCFD2 but not ERGIC-53-CRD undergoes significant conformational alterations upon complex formation. Our findings provide a structural basis for the cooperative interplay between ERGIC-53 and MCFD2 in capturing FV and FVIII.
凝血因子 V 和 VIII 联合缺乏症(F5F8D)是一种常染色体隐性疾病,其特征是血浆因子 V(FV)和因子 VIII(FVIII)水平协同降低,该疾病与跨膜凝集素 ERGIC-53 和可溶性钙结合蛋白 MCFD2 中的突变遗传相关。越来越多的证据表明,这两种蛋白质在 ER 和 ER-Golgi 中间隔室之间形成一个循环复合物,从而作为 FV 和 FVIII 的早期分泌途径中的货物受体发挥作用。为了更好地理解 ERGIC-53 和 MCFD2 功能协调的机制,我们通过 X 射线晶体学分析结合 NMR 和超速离心分析来表征它们的相互作用。综合数据的检查表明,ERGIC-53-CRD 通过远离糖结合位点的分子表面结合 MCFD2,导致复合物在溶液中形成。该相互作用不依赖于 ERGIC-53 的糖结合,并且涉及迄今为止在 F5F8D 中报道的 MCFD2 的大多数错义突变位点。与先前报道的每种蛋白质的未复合结构进行比较表明,MCFD2 而不是 ERGIC-53-CRD 在形成复合物时会发生显著的构象改变。我们的发现为 ERGIC-53 和 MCFD2 在捕获 FV 和 FVIII 中的协同作用提供了结构基础。